This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nzila, A. M.
Right arrow Articles by Watkins, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nzila, A. M.
Right arrow Articles by Watkins, W. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2000, p. 991-996, Vol. 44, No. 4
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites

A. M. Nzila,1,2,* E. K. Mberu,1,3 J. Sulo,4 H. Dayo,4 P. A. Winstanley,2 C. H. Sibley,3 and W. M. Watkins1,2

Kenya Medical Research Institute/Wellcome Trust Collaborative Research Program, Wellcome Trust Research Laboratories, Nairobi,1 and Center for Geographic Medicine Research, Coast, Kenya Medical Research Institute, Kilifi,4 Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3BX, United Kingdom2; and Department of Genetics, University of Washington, Seattle, Washington 98195-73603

Received 21 June 1999/Returned for modification 25 October 1999/Accepted 18 January 2000

The antifolate combination of pyrimethamine (PM) and sulfadoxine (SD) is the last affordable drug combination available for wide-scale treatment of falciparum malaria in Africa. Wherever this combination has been used, drug-resistant parasites have been selected rapidly. A study of PM-SD effectiveness carried out between 1997 and 1999 at Kilifi on the Kenyan coast has shown the emergence of RI and RII resistance to PM-SD (residual parasitemia 7 days after treatment) in 39 out of 240 (16.25%) patients. To understand the mechanism that underlies resistance to PM-SD, we have analyzed the dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genotypes of 81 patients. Fifty-one samples were obtained, before treatment, from patients who remained parasite free for at least 7 days after treatment. For a further 20 patients, samples were obtained before treatment and again when they returned to the clinic with parasites 7 days after PM-SD treatment. Ten additional isolates were obtained from patients who were parasitemic 7 days after treatment but who were not sampled before treatment. More than 65% of the isolates (30 of 46) in the initial group had wild-type or double mutant DHFR alleles, and all but 7 of the 47 (85%) had wild-type DHPS alleles. In the paired (before and after treatment) samples, the predominant combinations of DHFR and DHPS alleles before treatment were of triple mutant DHFR and double mutant DHPS (41% [7 of 17]) and of double mutant DHFR and double mutant DHPS (29% [5 of 17]). All except one of the posttreatment isolates had triple mutations in DHFR, and most of these were "pure" triple mutants. In these isolates, the combination of a triple mutant DHFR and wild-type DHPS was detected in 6 of 29 cases (20.7%), the combination of a triple mutant DHFR and a single mutant (A437G) DHPS was detected in 4 of 29 cases (13.8%), and the combination of a triple mutant DHFR and a double mutant (A437G, L540E) DHPS was detected in 16 of 29 cases (55.2%). These results demonstrate that the triply mutated allele of DHFR with or without mutant DHPS alleles is associated with RI and RII resistance to PM-SD. The prevalence of the triple mutant DHFR-double mutant DHPS combination may be an operationally useful marker for predicting the effectiveness of PM-SD as a new malaria treatment.

* Corresponding author. Mailing address: Wellcome Trust Research Laboratories, P.O. Box 43640, Nairobi, Kenya. Phone: 2542 725 390. Fax: 254 2 711 673. E-mail: anzila{at}WTRL.OR.KE.

Antimicrobial Agents and Chemotherapy, April 2000, p. 991-996, Vol. 44, No. 4
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kiara, S. M., Okombo, J., Masseno, V., Mwai, L., Ochola, I., Borrmann, S., Nzila, A. (2009). In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation. Antimicrob. Agents Chemother. 53: 3793-3798 [Abstract] [Full Text]  
  • Lozovsky, E. R., Chookajorn, T., Brown, K. M., Imwong, M., Shaw, P. J., Kamchonwongpaisan, S., Neafsey, D. E., Weinreich, D. M., Hartl, D. L. (2009). Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl. Acad. Sci. USA 106: 12025-12030 [Abstract] [Full Text]  
  • Dahlstrom, S., Veiga, M. I., Martensson, A., Bjorkman, A., Gil, J. P. (2009). Polymorphism in PfMRP1 (Plasmodium falciparum Multidrug Resistance Protein 1) Amino Acid 1466 Associated with Resistance to Sulfadoxine-Pyrimethamine Treatment. Antimicrob. Agents Chemother. 53: 2553-2556 [Abstract] [Full Text]  
  • Ochong, E., Bell, D. J., Johnson, D. J., D'Alessandro, U., Mulenga, M., Muangnoicharoen, S., Van Geertruyden, J.-P., Winstanley, P. A., Bray, P. G., Ward, S. A., Owen, A. (2008). Plasmodium falciparum Strains Harboring Dihydrofolate Reductase with the I164L Mutation Are Absent in Malawi and Zambia Even under Antifolate Drug Pressure. Antimicrob. Agents Chemother. 52: 3883-3888 [Abstract] [Full Text]  
  • McCollum, A. M., Basco, L. K., Tahar, R., Udhayakumar, V., Escalante, A. A. (2008). Hitchhiking and Selective Sweeps of Plasmodium falciparum Sulfadoxine and Pyrimethamine Resistance Alleles in a Population from Central Africa. Antimicrob. Agents Chemother. 52: 4089-4097 [Abstract] [Full Text]  
  • Mayxay, M., Nair, S., Sudimack, D., Imwong, M., Tanomsing, N., Pongvongsa, T., Phompida, S., Phetsouvanh, R., White, N. J., Anderson, T. J. C., Newton, P. N. (2007). Combined Molecular and Clinical Assessment of Plasmodium falciparum Antimalarial Drug Resistance in the Lao People's Democratic Republic (Laos). Am J Trop Med Hyg 77: 36-43 [Abstract] [Full Text]  
  • Carnevale, E. P., Kouri, D., DaRe, J. T., McNamara, D. T., Mueller, I., Zimmerman, P. A. (2007). A Multiplex Ligase Detection Reaction-Fluorescent Microsphere Assay for Simultaneous Detection of Single Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance. J. Clin. Microbiol. 45: 752-761 [Abstract] [Full Text]  
  • Mockenhaupt, F. P., Bedu-Addo, G., Junge, C., Hommerich, L., Eggelte, T. A., Bienzle, U. (2007). Markers of Sulfadoxine-Pyrimethamine-Resistant Plasmodium falciparum in Placenta and Circulation of Pregnant Women. Antimicrob. Agents Chemother. 51: 332-334 [Abstract] [Full Text]  
  • MENARD, D., YAPOU, F., MANIRAKIZA, A., DJALLE, D., MATSIKA-CLAQUIN, M. D., TALARMIN, A. (2006). Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from bangui, central african republic.. Am J Trop Med Hyg 75: 381-387 [Abstract] [Full Text]  
  • TAHAR, R., BASCO, L. K. (2006). Molecular epidemiology of malaria in cameroon. Xxii. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles.. Am J Trop Med Hyg 75: 396-401 [Abstract] [Full Text]  
  • Gatton, M. L., Cheng, Q. (2006). Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine. J Antimicrob Chemother 58: 47-51 [Abstract] [Full Text]  
  • COHUET, S., BONNET, M., VAN HERP, M., VAN OVERMEIR, C., D'ALESSANDRO, U., GUTHMANN, J.-P. (2006). Molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the democratic republic of congo.. Am J Trop Med Hyg 75: 152-154 [Abstract] [Full Text]  
  • HAPUARACHCHI, H. C., DAYANATH, M. Y. D., BANDARA, K. B. A. T., ABEYSUNDARA, S., ABEYEWICKREME, W., DE SILVA, N. R., HUNT, S. Y., SIBLEY, C. H. (2006). POINT MUTATIONS IN THE DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE GENES OF PLASMODIUM FALCIPARUM AND RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SRI LANKA. Am J Trop Med Hyg 74: 198-204 [Abstract] [Full Text]  
  • MENARD, D., DJALLE, D., YAPOU, F., MANIRAKIZA, A., TALARMIN, A. (2006). FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN BANGUI, CENTRAL AFRICAN REPUBLIC. Am J Trop Med Hyg 74: 205-210 [Abstract] [Full Text]  
  • GEBRU-WOLDEAREGAI, T., HAILU, A., GROBUSCH, M. P., KUN, J. F. J. (2005). MOLECULAR SURVEILLANCE OF MUTATIONS IN DIHYDROFOLATE REDUCTASE AND DIHYROPTEROATE SYNTHASE GENES OF PLASMODIUM FALCIPARUM IN ETHIOPIA. Am J Trop Med Hyg 73: 1131-1134 [Abstract] [Full Text]  
  • Nduati, E., Hunt, S., Kamau, E. M., Nzila, A. (2005). 2,4-Diaminopteridine-Based Compounds as Precursors for De Novo Synthesis of Antifolates: a Novel Class of Antimalarials. Antimicrob. Agents Chemother. 49: 3652-3657 [Abstract] [Full Text]  
  • Gregson, A., Plowe, C. V. (2005). Mechanisms of Resistance of Malaria Parasites to Antifolates. Pharmacol. Rev. 57: 117-145 [Abstract] [Full Text]  
  • WATKINS, W. M., SIBLEY, C. H., HASTINGS, I. M. (2005). THE SEARCH FOR EFFECTIVE AND SUSTAINABLE TREATMENTS FOR PLASMODIUM FALCIPARUM MALARIA IN AFRICA: A MODEL OF THE SELECTION OF RESISTANCE BY ANTIFOLATE DRUGS AND THEIR COMBINATIONS. Am J Trop Med Hyg 72: 163-173 [Abstract] [Full Text]  
  • MUGITTU, K., NDEJEMBI, M., MALISA, A., LEMNGE, M., PREMJI, Z., MWITA, A., NKYA, W., KATARAIHYA, J., ABDULLA, S., BECK, H.-P., MSHINDA, H. (2004). THERAPEUTIC EFFICACY OF SULFADOXINE-PYRIMETHAMINE AND PREVALENCE OF RESISTANCE MARKERS IN TANZANIA PRIOR TO REVISION OF MALARIA TREATMENT POLICY: PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE MUTATIONS IN MONITORING IN VIVO RESISTANCE. Am J Trop Med Hyg 71: 696-702 [Abstract] [Full Text]  
  • DORSEY, G., DOKOMAJILAR, C., KIGGUNDU, M., STAEDKE, S. G., KAMYA, M. R., ROSENTHAL, P. J. (2004). PRINCIPAL ROLE OF DIHYDROPTEROATE SYNTHASE MUTATIONS IN MEDIATING RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SINGLE-DRUG AND COMBINATION THERAPY OF UNCOMPLICATED MALARIA IN UGANDA. Am J Trop Med Hyg 71: 758-763 [Abstract] [Full Text]  
  • Ommeh, S., Nduati, E., Mberu, E., Kokwaro, G., Marsh, K., Rosowsky, A., Nzila, A. (2004). In Vitro Activities of 2,4-Diaminoquinazoline and 2,4-Diaminopteridine Derivatives against Plasmodium falciparum. Antimicrob. Agents Chemother. 48: 3711-3714 [Abstract] [Full Text]  
  • Mbaisi, A., Liyala, P., Eyase, F., Achilla, R., Akala, H., Wangui, J., Mwangi, J., Osuna, F., Alam, U., Smoak, B. L., Davis, J. M., Kyle, D. E., Coldren, R. L., Mason, C., Waters, N. C. (2004). Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of Kenya. Antimicrob. Agents Chemother. 48: 3598-3601 [Abstract] [Full Text]  
  • Alker, A. P., Mwapasa, V., Meshnick, S. R. (2004). Rapid Real-Time PCR Genotyping of Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 48: 2924-2929 [Abstract] [Full Text]  
  • Talisuna, A. O., Bloland, P., D'Alessandro, U. (2004). History, Dynamics, and Public Health Importance of Malaria Parasite Resistance. Clin. Microbiol. Rev. 17: 235-254 [Abstract] [Full Text]  
  • SYAFRUDDIN, D., ASIH, P. B. S., AGGARWAL, S. L., SHANKAR, A. H. (2003). FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN PURWOREJO DISTRICT, CENTRAL JAVA PROVINCE, INDONESIA. Am J Trop Med Hyg 69: 614-620 [Abstract] [Full Text]  
  • Plowe, C. V. (2003). Monitoring antimalarial drug resistance: making the most of the tools at hand. J. Exp. Biol. 206: 3745-3752 [Abstract] [Full Text]  
  • KYABAYINZE, D., CATTAMANCHI, A., KAMYA, M. R., ROSENTHAL, P. J., DORSEY, G. (2003). VALIDATION OF A SIMPLIFIED METHOD FOR USING MOLECULAR MARKERS TO PREDICT SULFADOXINE-PYRIMETHAMINE TREATMENT FAILURE IN AFRICAN CHILDREN WITH FALCIPARUM MALARIA. Am J Trop Med Hyg 69: 247-252 [Abstract] [Full Text]  
  • BASCO, L. K. (2003). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XVI. LONGITUDINAL SURVEILLANCE OF IN VITRO PYRIMETHAMINE RESISTANCE IN PLASMODIUM FALCIPARUM. Am J Trop Med Hyg 69: 174-178 [Abstract] [Full Text]  
  • OCHONG', E. O., VAN DEN BROEK, I. V. F., KEUS, K., NZILA, A. (2003). SHORT REPORT: ASSOCIATION BETWEEN CHLOROQUINE AND AMODIAQUINE RESISTANCE AND ALLELIC VARIATION IN THE PLASMODIUM FALCIPARUM MULTIPLE DRUG RESISTANCE 1 GENE AND THE CHLOROQUINE RESISTANCE TRANSPORTER GENE IN ISOLATES FROM THE UPPER NILE IN SOUTHERN SUDAN. Am J Trop Med Hyg 69: 184-187 [Abstract] [Full Text]  
  • Nzila, A., Mberu, E., Bray, P., Kokwaro, G., Winstanley, P., Marsh, K., Ward, S. (2003). Chemosensitization of Plasmodium falciparum by Probenecid In Vitro. Antimicrob. Agents Chemother. 47: 2108-2112 [Abstract] [Full Text]  
  • Aubouy, A., Jafari, S., Huart, V., Migot-Nabias, F., Mayombo, J., Durand, R., Bakary, M., Le Bras, J., Deloron, P. (2003). DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 52: 43-49 [Abstract] [Full Text]  
  • Pearce, R. J., Drakeley, C., Chandramohan, D., Mosha, F., Roper, C. (2003). Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania. Antimicrob. Agents Chemother. 47: 1347-1354 [Abstract] [Full Text]  
  • Hayton, K., Ranford-Cartwright, L. C., Walliker, D. (2002). Sulfadoxine-Pyrimethamine Resistance in the Rodent Malaria Parasite Plasmodium chabaudi. Antimicrob. Agents Chemother. 46: 2482-2489 [Abstract] [Full Text]  
  • Mendez, F., Munoz, A., Carrasquilla, G., Jurado, D., Arevalo-Herrera, M., Cortese, J. F., Plowe, C. V. (2002). Determinants of Treatment Response to Sulfadoxine-Pyrimethamine and Subsequent Transmission Potential in Falciparum Malaria. Am J Epidemiol 156: 230-238 [Abstract] [Full Text]  
  • Kovacs, J. A., Gill, V. J., Meshnick, S., Masur, H. (2001). New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA 286: 2450-2460 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»